Don’t miss the latest developments in business and finance.

Medicamen Biotech signs CDMO agreement with Vital Pharma Nordic

Image
Capital Market
Last Updated : Aug 12 2022 | 4:31 PM IST
Medicamen Biotech has entered into long term agreement with Vital Pharma Nordic, a Denmark based company, for CDMO for multiple products.

Vital Pharma Nordic is led by highly experienced specialists and engaged in licensing, development, distribution and sales of specialty Gx pharmaceuticals. VPN operate in the Nordic region now expanding internationally.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Aug 12 2022 | 4:16 PM IST

Next Story